Schulman S - Search Results

1

Recombinant factor VIIa in multiple surgery.

Schulman S, Lindstedt M, Alberts KA, Agren PH. Schulman S, et al. Thromb Haemost. 1994 Jan;71(1):154. Thromb Haemost. 1994. PMID: 8165636 No abstract available.

2

Successful use of recombinant factor VIIa in patient with severe haemophilia A during synovectomy.

Hedner U, Glazer S, Pingel K, Alberts KA, Blombäck M, Schulman S, Johnsson H. Hedner U, et al. Among authors: schulman s. Lancet. 1988 Nov 19;2(8621):1193. doi: 10.1016/s0140-6736(88)90259-0. Lancet. 1988. PMID: 2903400 No abstract available.

3

Feasibility of using recombinant factor VIIa in continuous infusion.

Schulman S, Bech Jensen M, Varon D, Keller N, Gitel S, Horoszowski H, Heim M, Martinowitz U. Schulman S, et al. Thromb Haemost. 1996 Mar;75(3):432-6. Thromb Haemost. 1996. PMID: 8701403

4

Experiences with continuous infusion of recombinant activated factor VII.

Schulman S, d'Oiron R, Martinowitz U, Pasi J, Briquel ME, Mauser-Bunschoten E, Morfini M, Ritchie B, Goudemand J, Lloyd J, McPherson J, Négrier C, Peerlinck K, Petrini P, Tusell J. Schulman S, et al. Blood Coagul Fibrinolysis. 1998 Mar;9 Suppl 1:S97-101. Blood Coagul Fibrinolysis. 1998. PMID: 9819037 Clinical Trial.

5

Continuous infusion of recombinant factor VIIa in hemophilic patients with inhibitors: safety, monitoring, and cost effectiveness.

Schulman S; rFVIIa-CI Group. Schulman S, et al. Semin Thromb Hemost. 2000;26(4):421-4. doi: 10.1055/s-2000-8462. Semin Thromb Hemost. 2000. PMID: 11092218 Review.

6

Monoclonal purified F VIII for continuous infusion: stability, microbiological safety and clinical experience.

Schulman S, Varon D, Keller N, Gitel S, Martinowitz U. Schulman S, et al. Thromb Haemost. 1994 Sep;72(3):403-7. Thromb Haemost. 1994. PMID: 7855792 Clinical Trial.

7

Safety and efficacy of continuous infusion of a combined factor VIII-von Willebrand factor (vWF) concentrate (Haemate-P) in patients with von Willebrand disease.

Lubetsky A, Schulman S, Varon D, Martinowitz U, Kenet G, Gitel S, Inbal A. Lubetsky A, et al. Among authors: schulman s. Thromb Haemost. 1999 Feb;81(2):229-33. Thromb Haemost. 1999. PMID: 10063997

8

Thrombotic complications after substitution with a FVII concentrate.

Schulman S, Johnsson H, Lindmarker P. Schulman S, et al. Thromb Haemost. 1991 Nov 1;66(5):619. Thromb Haemost. 1991. PMID: 1803627 No abstract available.

9

The onerous task of comparing treatments in inhibitor patients.

Schulman S. Schulman S. Thromb Haemost. 2007 Oct;98(4):710-2. Thromb Haemost. 2007. PMID: 17938791 No abstract available.

10

Fibrin sealant in surgery of patients with a hemorrhagic diathesis.

Martinowitz U, Schulman S. Martinowitz U, et al. Among authors: schulman s. Thromb Haemost. 1995 Jul;74(1):486-92. Thromb Haemost. 1995. PMID: 8578511 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

939 results

Search Page